1. Uzan, J, Carbonnel, M, Piconne, O, Asmar, R, Ayoubi, J-M: Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag. 2011;7:467–474.
Google Scholar | Medline2. Shamsi, U, Saleem, S, Nishter, N, Ameen, A: Epidemiology and risk factors of preeclampsia; an overview of observational studies. Al Ameen J Med Sci. 2013;6(4):292–300.
Google Scholar3. Umapathy, A, Chamley, LW, James, JL: Reconciling the distinct roles of angiogenic/anti-angiogenic factors in the placenta and maternal circulation of normal and pathological pregnancies. Angiogenesis. 2020;23:105–117.
Google Scholar | Crossref | Medline4. Krishna, U, Bhalerao, S: Placental insufficiency and fetal growth restriction. J Obstet Gynecol India. 2011;61(5):505–511.
Google Scholar | Crossref5. Ridder, A, Giorgione, V, Khalil, A, Thilaganathan, B: Preeclampsia: the relationship between uterine artery blood flow and trophoblast function. Int J Mol Sci. 2019;20(13):3263.
Google Scholar | Crossref6. He, B, Hu, C, Zhou, Y: First-trimester screening for fetal growth restriction using Doppler color flow analysis of the uterine artery and serum PAPP-A levels in unselected pregnancies. The Journal of Maternal-Fetal & Neonatal Medicine. 2020; 11:1–5. doi:10.1080/14767058.2019.1701646.
Google Scholar | Crossref7. Khong, SL, Kane, SC, Brennecke, SP, da Silva Costa, F: First-trimester uterine artery Doppler analysis in the prediction of later pregnancy complications. Dis Markers. 2015;2015:679730–679710. doi:10.1155/2015/679730.
Google Scholar | Crossref | Medline8. Goetzinger, KR, Singla, A, Gerkowicz, S, Dicke, JM, Gray, DL, Odibo, AO: Predicting the risk of pre-eclampsia between 11 and 13 weeks’ gestation by combining maternal characteristics and serum analytes, PAPP-A and free β-hCG. Prenat Diagn. 2010;30(12–13):1138–1142.
Google Scholar | Crossref | Medline9. Audibert, F, Benchimol, Y, Benattar, C, Champagne, C, Frydman, R: Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry. Fetal Diagn Ther. 2005;20(1):48–53.
Google Scholar | Crossref | Medline10. Dayal, M, Gupta, P, Varma, M, Ghosh, UK, Bhargava, A: Role of second trimester maternal serum markers as predictor of preeclampsia. J Obstet Gynecol India. 2011;61(1):38–41.
Google Scholar | Crossref11. Schaller, S, Knippel, AJ, Verde, PE, Kozlowski, P: Concordance-analysis and evaluation of different diagnostic algorithms used in first trimester screening for late-onset preeclampsia. Hypertens Pregnancy. 2020;39(2):172–185.
Google Scholar | Crossref | Medline12. Li, L, Zheng, Y, Zhu, Y, Li, J: Serum biomarkers combined with uterine artery Doppler in prediction of preeclampsia. Exp Ther Med. 2016;12(4):2515–2520.
Google Scholar | Crossref | Medline13. Vangrieken, P, Al-Nasiry, S, Bast, A, et al: Placental mitochondrial abnormalities in preeclampsia. Reprod Sci. 2021;28(8):2186–2199.
Google Scholar | Crossref | Medline14. Melchiorre, K, Giorgione, V, Thilaganathan, B: The placenta and preeclampsia: villain or victim? [published online ahead of print March 24, 2021]. Am J Obstet Gynecol. doi:10.1016/j.ajog.2020.10.024.
Google Scholar | Crossref15. Abdallah, A, Khairy, M, Tawfik, M, et al: Role of first-trimester 3D power Doppler of placental blood flow and 3D placental volume in early prediction of preeclampsia. Int J Gynecol Obstet. 2021;154:466–473.
Google Scholar | Crossref | Medline16. Pankiewicz, K, Szczerba, E, Maciejewski, T, Fijałkowska, A: Non-obstetric complications in preeclampsia. Prz Menopauzalny. 2019;18(2):99–109.
Google Scholar | Medline17. Degner, K, Magness, RR, Shah, DM: Establishment of the human uteroplacental circulation: a historical perspective. Reprod Sci. 2017;24(5):753–761. doi:10.1177/1933719116669056.
Google Scholar | SAGE Journals | ISI18. Nomura, Y, Finik, J, Salzbank, J, et al: The effects of preeclampsia on perinatal risks and infant temperaments among mothers with antenatal depression. Psychol Res (Libertyville). 2014;4(6):451–461. doi:10.17265/2159-5542/2014.06.005.
Google Scholar | Crossref | Medline19. Roberts, JM, Rich-Edwards, JW, McElrath, TF, Garmire, L, Myatt, L, Global Pregnancy Collaboration : Subtypes of preeclampsia: recognition and determining clinical usefulness. Hypertension. 2021;77(5):1430–1441.
Google Scholar | Crossref | Medline20. Zwertbroek, EF, Groen, H, Fontanella, F, Maggio, L, Marchi, L, Bilardo, CM: Performance of the FMF first-trimester preeclampsia-screening algorithm in a high-risk population in the Netherlands. Fetal Diagn Ther. 2021;48(2):103–111.
Google Scholar | Medline21. Rolnik, DL, Nicolaides, KH, Poon, LC: Prevention of preeclampsia with aspirin. Am J Obstet Gynecol. 2020; 21: S0002–9378(20)30873 -5. doi: 10.1016/j.ajog.2020.08.045. Epub ahead of print. PMID: 32835720.
Google Scholar | Crossref22. O’Gorman, N, Wright, D, Poon, LC, et al: Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation: comparison with NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol. 2017;49(6):756–760. doi:10.1002/uog.17455.
Google Scholar | Crossref | Medline | ISI23. Chaemsaithong, P, Sahota, DS, Poon, LC: First trimester preeclampsia screening and prediction. Am J Obstet Gynecol. 2020; 16: S0002-9378(20)30741–9. doi: 10.1016/j.ajog.2020.07.020. Epub ahead of print. PMID: 32682859.
Google Scholar | Crossref24. Al-Rubaie, ZT, Hudson, HM, Jenkins, G, et al: Prediction of pre-eclampsia in nulliparous women using routinely collected maternal characteristics: a model development and validation study. BMC Pregnancy Childbirth. 2020;20(1):23.
Google Scholar | Crossref | Medline25. Tan, M, Wright, D, Syngelaki, A, et al: Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE. Ultrasound Obstet Gynecol. 2018;51(6):743–750.
Google Scholar | Crossref | Medline26. Al-Rubaie, ZT, Askie, LM, Hudson, HM, Ray, JG, Jenkins, G, Lord, SJ: Assessment of NICE and USPSTF guidelines for identifying women at high risk of pre-eclampsia for tailoring aspirin prophylaxis in pregnancy: an individual participant data meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2018;229:159–166.
Google Scholar | Crossref | Medline27. Cnossen, JS, Morris, RK, ter Riet, G, et al: Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ. 2008;178(6):701–711.
Google Scholar | Crossref | Medline28. Pongrojpaw, D, Chanthasenanont, A, Nanthakomon, T: Second trimester uterine artery Doppler screening in prediction of adverse pregnancy outcome in high risk women. J Med Assoc Thai. 2010;93(Suppl. 7):S127–S130.
Google Scholar | Medline29. Oancea, M, Grigore, M, Ciortea, R, et al: Uterine artery Doppler ultrasonography for first trimester prediction of preeclampsia in individuals at risk from low-resource settings. Medicina (Mex). 2020;56(9):428.
Google Scholar | Crossref30. Rifat, AG : Doppler ultrasound screening of the uterine arteries as a predictor for early miscarriage. Int J Women’s Health Reprod Sci. 2020;8(1):79–84.
Google Scholar | Crossref31. Elwakel, AM, Azab, SM, Elbakry, AM: First-trimester uterine artery Doppler in the prediction of later pregnancy complication. Menoufia Med J. 2020;33(3):966–971.
Google Scholar32. Murtoniemi, K, Villa, PM, Matomäki, J, et al: Prediction of pre-eclampsia and its subtypes in high-risk cohort: hyperglycosylated human chorionic gonadotropin in multivariate models. BMC Pregnancy Childbirth. 2018;18(1):279. doi:10.1186/s12884-018-1908-9.
Google Scholar | Crossref | Medline33. Prasad, LVV, Trinadh, Y, Reddy, K: Role of first and second trimester uterine artery Doppler in prediction of pre-eclampsia. J Med Sci Clin Res. 2019;7(7). doi:10.18535/jmscr/v7i7.137: 770–777.
Google Scholar | Crossref34. Jones, SL, Aviram, A, Porto, L, et al: Uterine artery Doppler to predict growth restriction in cases of abnormal first trimester analytes. Placenta. 2021;106:22–24.
Google Scholar | Crossref | Medline35. Yu, N, Cui, H, Chen, X, Chang, Y: First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction. Taiwan J Obstet Gynecol. 2017;56(3):358–361. doi:10.1016/j.tjog.2017.01.009.
Google Scholar | Crossref | Medline36. Nese, KZ, Basgul, A, Elter, K, Uygur, M, Gokaslan, H: The efficacy of first-trimester PAPP-A and free β-hCG levels for predicting adverse pregnancy outcome. J Perinat Med. 2006;34(2):145–148. doi:10.1515/JPM.2006.026.
Google Scholar | Crossref | Medline37. Barjaktarovic, M, Korevaar, T, Jaddoe, V, de Rijke, YB, Peeters, RP, Steegers, EAP: Human chorionic gonadotropin and risk of pre-eclampsia: prospective population-based cohort study. Ultrasound Obstet Gynecol. 2019;54(4):477–483.
Google Scholar | Crossref | Medline38. Di Lorenzo, G, Ceccarello, M, Cecotti, V, et al: First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia. Placenta. 2012;33(6):495–501. doi:10.1016/j.placenta.2012.03.003.
Google Scholar | Crossref | Medline | ISI